OOIR: Observatory of International Research

Papers

(The TQCC of Biologicals is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)

Article	Citations
Aims and Scope/Editorial Board/Publishing Details	20
Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshop	19
EGF domain peptide of Developmentally regulated endothelial locus1 facilitates gene expression of extracellularly applied plasmid DNA	15
Outer membrane vesicles as nanovaccine candidates against pathogenic Leptospira in experimental Guinea pig model	11
Nanoparticle formulation for the development of a dog nanovaccine against Cystic Echinococcosis	11
The development and establishment of a heat inactivated preparation of Mycobacterium tuberculosis (H37Rv) as the first international standard for nucleic acid amplification techniques	11
A validated polyclonal antiserum-based immunoassay for assessment of HPV 16 L1 relative potency	11
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Reports from a series of NC3Rs stakeholder workshops	11
Production and characterization of monoclonal antibodies against hepatitis B e-antigen and their potential application for development of HBeAg detection ELISA	10
Potential therapeutic effects of hAMSCs secretome on Panc1 pancreatic cancer cells through downregulation of SgK269, E-cadherin, vimentin, and snail expression	10
Validation of a next generation sequencing method for adventitious virus detection: Demonstration of sensitivity in multiple cell lines	9
Aims and Scope/Editorial Board/Publishing Details	9
Global availability of critical reagents for biologicals testing - Current status, challenges and possible solutions	8
Glycosylation differences of an anti-VEGF monoclonal antibody (PRO-169) and its extensive comparison with Bevacizumab	8
Regulatory workshop on challenge strain development and GMP manufacture – A stakeholder meeting report	8
A species-independent indirect-ELISA for detection of antibodies to the non-structural protein 2B of foot-and-mouth disease virus	8
Replacement of in vivo leptospirosis vaccine potency testing in the United States	7
Animal cell substrates for the production of biologicals: An introduction to WHO documents	7
Ethical approval for controlled human infectious model clinical trial protocols – A workshop report	7
The future of pyrogenicity testing: Phasing out the rabbit pyrogen test. A meeting report	7
IABS/DCVMN webinar on next generation sequencing	7
Nano-emulsion encapsulation for the efficient delivery of bacteriophage therapeutics	7
Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report	6
Evaluation of the focus reduction neutralization and ELISA tests compared to the plaque reduction neutralization test for the detection of antibodies against measles virus	6
Glycoconjugation of Shigella flexneri type 2a O-polysaccharide with CRM197 as a potential vaccine candidate for shigellosis	6

Collaborative study for the calibration of a replacement International Standard for Diphtheria Antitoxin Equine	6
A rapid and simple sterility test method based on solid culture medium containing blood	6
Evaluation of candidate International Standards for meningococcal capsular polysaccharide groups W and Y	6
In silico discovery of epitopes of gag and env proteins for the development of a multi-epitope vaccine candidate against Maedi Visna Virus using reverse vaccinology approach	6
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals	6
Development and comparison of three cell-based potency assays for anti-respiratory syncytial virus monoclonal antibody	5
Aims and Scope/Editorial Board/Publishing Details	5
An adventitious agent-free clonal cell line that is highly susceptible to foot -and-mouth disease virus	5
Development and evaluation of an external quality control and internal quality control containing real-time RT-PCR assay for the detection of o'nyong-nyong virus	5
Expression profiling of inflammation-related genes including IFI-16, NOTCH2, CXCL8, THBS1 in COVID-19 patients	5
Novel vaccine candidates of Bordetella pertussis identified by reverse vaccinology	5
Mass spectrometry analysis of bovine tuberculins - 3R potential in batch potency testing	4
Assessment of the risks associated with the use of in vivo versus in vitro potency tests for vaccines	4
Maintaining the quality of vaccines through the use of standards: Current challenges and future opportunities	4
Designing multi-epitope vaccine against human cytomegalovirus integrating pan-genome and reverse vaccinology pipelines	4
Aims and Scope/Editorial Board/Publishing Details	4
Future of TABST and LABST in the Indian Pharmacopoeia Monographs A Humane Society International/India Workshop Report	4
Aims and Scope/Editorial Board/Publishing Details	4
Glycoconjugate content quantification to assess vaccine potency: A simplified approach	4
Animal experiments show impact of vaccination on reduction of SARS-CoV-2 virus circulation: A model for vaccine development?	3
Aims and Scope/Editorial Board/Publishing Details	3
Prevalence of viral agents causing swine reproductive failure in Korea and the development of multiplex real-time PCR and RT-PCR assays	3
Development of an optimized RT-LAMP test for the detection of SARS-CoV-2	3
Klebsiella pneumoniae vaccine studies in animal models	3
The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report	3
Obituary - Inessa LEVENBOOK: 1926–2022	3
Report for the Eighth Asian National Control Laboratory Network meeting in 2023: Self-sufficiency strategy of plasma-derived medicinal products and regulatory harmonisation	3
Enabling the evaluation of COVID-19 vaccines with correlates of protection	3
Autogenous vaccines: Quality of production and movement in a common market	3
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Responses from a survey of National Control Laboratories and National Regulatory Authorities	3
Aims and Scope/Editorial Board/Publishing Details	3
Risk assessment for biopharmaceutical single-use manufacturing: A case study of upstream continuous processing	3
Evolution of FMT – From early clinical to standardized treatments	3
From eradication to re-emergence: The changing landscape of polio in the cVDPV2 era	3